Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71205-623

This is a medication with the name Sidenafl containing Sildenafil 20mg, in film-coated tablets form, and packaged in 90-tablet bottles. It comes with a lot number and an expiration date, and it should be stored at temperatures between 20%25°C (68°-77°F). The manufacturer is Rubicon Research Private Limited in India, and it has been relabeled by Proficient Rx LP in Thousand Oaks, California. The product is available by prescription only and should be kept out of reach of children.*

This seems to be a table or a chart that probably contains information about the interaction between drugs and the recommended dose adjustment. The table lists several drugs, such as Acitomycin, Bosentan, Cimetidines, Evomyeint, Maslox, Oral Contraceptives, Rionavit, and Sapionis, and their corresponding recommended nodose adjustments. The table also contains abbreviations such as AUC and Cmax, which may indicate the maximum concentration of a drug in the body after administration. However, without additional context or information, it is difficult to provide a more precise description of the content.*

This is a drug interaction table indicating that Acenocoumarol, an anticoagulant used to prevent blood clots interacts with several different drugs such as aspirin, atorvastatin, Doxazosin, Ethinyloestradiol, Levonorgestrel, and Tolbutamide. The table suggests that these interactions are manageable and most of the time, patients do not need a dose adjustment. However, there is a warning for co-administration of Acenocoumarol with Saquinavir and Ritonavir, which are HIV protease inhibitors as it is not recommended. The table also provides information on the fold change and 90% CI recommendation for dose adjustments. The description concludes with a sentence warning that there's no benefit from adding Sildenafil to bosentan therapy to improve exercise capacity and that the effect of Ritonavir on Sildenafil PK is the basis for not recommending co-administration.*

This is a table that shows the change from the baseline measured in meters at weeks 4, 8, and 12 of a study. The different treatment groups are indicated by symbols and names (placebo, Sildenafil 20mg TID, Sildenafil 40mg TID, and Sildenafil 80mg TID). There is no further information about the study or the purpose of the measurements.*

This appears to be a medical document discussing the use of Sildenafil to treat idiopathic pulmonary arterial hypertension. The document shows tables and graphs with data related to patient age, gender, and response to medication. It also appears to measure the effectiveness of the medication using a 6-minute walk test.*